Location: Home
  • search
  • go
  • Relate News
  • 6/29/2023Coherent Took the Lion's Share of China's Venture Financing Deals in M...
  • 6/26/2023China Saw Cross-border Pharma Deals Surge by 68% in May (PharmaDJ)
  • 6/26/2023CDE Solicits Comments on the Technical Guidelines for Non-clinical Res...
  • 6/23/2023Considerations for Registering Pharmaceutical Trademarks in China and ...
  • 6/20/2023Chinese Drugmakers Showcased Clinical Progress in ADC, CAR-T and PD-1 ...
  • 6/16/2023China Launches Three-year Campaign to Fight Alzheimer's Disease
  • 6/13/2023NMPA Announces Package Insert Revision of Betahistine Preparations
  • 5/30/2023Adcendo Expands ADC License Deal with Duality Biologics
  • 5/29/2023April Sees Deals Worth $2.8B in ADCs, CAR-T Therapies and More (Pharma...
  • 5/19/2023April Fundraising Rebounds with $315M Capital Injection to Hasten Biop...
  • 5/15/2023China Beefs Up Mental Health Efforts with a New Guideline
  • 5/12/2023 AstraZeneca and LaNova Medicines Enter Global License Deal for GPRC5D...
  • 5/9/20232023Q1 China Biopharma Ventures, IPOs and Deals (PharmaDJ)
  • 5/8/2023Bliss and Eisai Enter Clinical Trial Collaboration with Strategic Opti...
  • 4/27/2023Zai Lab Announces Global Deal with MediLink for a Next Gen ADC Program...
  • 4/25/2023NMPA Announces Package Insert Revision of Additional Two Drug Products
  • 4/25/2023NMPA Issues the Opinions for Improving Review and Approval of Radiopha...
  • 4/25/2023Despite Strong Year-on-Year Growth in Q1, Licensing Deals Slow in Marc...
  • 4/24/2023NMPA Announces Package Insert Revision of Multiple Drug Products
  • 4/17/2023Financing for Chinese Drugmakers Hit a Slump in March (PharmaDJ)
  • 4/14/2023Review of China's Foreign Trade of Medicines and Health Products in 20...
  • 4/5/2023China's Out-Licensing Boom Continued in February with Big Oncology Dru...
  • 4/4/2023Antibody-drug Conjugates Gain Traction in China Oncology Market: Globa...
  • 4/3/2023BioNTech and DualityBio Form Global Strategic Partnership to Accelerat...
  • 3/24/2023NMPA Publishes the 2022 Annual Report for Adverse Drug Reaction Monito...
  • 3/20/2023TOT Biopharm Terminates Development of Its HER2 ADC TAA013 in China Du...
  • 3/16/2023China Biotech Fundraising Up Sharply in February as Six Drugmakers Iss...
  • 3/14/2023Study: Alzheimer's Disease Awareness and Acceptance Is Low in China
  • 3/6/2023US Adds 37 Chinese Firms to Trade Blacklist, Including Units of BGI
  • 2/24/2023The Out-Licensing Boom Continues, Orphan Drugs May Be on the Rise (Pha...
  • Page:3/25 Total number of articles:748: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group